ELIOS achieved statistically significant, clinically meaningful IOP lowering, meeting both co-primary endpoints for responder ...
Medium-dose OCU410 met the 12-month primary endpoint, reducing GA lesion growth by 31% versus control (P < .05), with ...
A study shows the potential for tilt and tumble cataract surgery to improve efficiency without compromising safety or visual acuity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results